Opportunity Information: Apply for COOCLI1
The Combating Opioid Overdose through Community-Level Intervention opportunity is a federal funding initiative from the Office of National Drug Control Policy (ONDCP) within the Executive Office of the President. It is designed to strengthen local and regional responses to the opioid overdose epidemic by funding a single recipient to carry out hands-on, community-based work that combines implementation with rigorous evaluation. The overall intent is not just to support interventions, but to build practical evidence about what works in real-world communities, particularly in parts of the country experiencing the highest levels of fatal and non-fatal opioid overdoses. A central theme of the program is improving coordination across systems that often operate separately, especially public health and law enforcement, since stronger alignment between these sectors is viewed as essential to reducing overdose deaths and other harms tied to opioid misuse.
ONDCP planned to make one cooperative agreement award for a one-year project period beginning around September 2019. The award was posted as a discretionary grant in the health funding category (CFDA 95.007), with an anticipated award ceiling of $4,500,000 and one expected award. As a cooperative agreement, the project is framed as a close working relationship where ONDCP (and related efforts at CDC) would remain engaged with the recipient, and the funded work is expected to align with, and be informed by, related federal overdose response activities. The program specifically connects to the High Intensity Drug Trafficking Areas (HIDTA) program, which is funded by ONDCP and already collaborates with CDC through the Overdose Response Strategy initiative, making HIDTA partnerships a core structural requirement rather than an optional collaboration.
The work ONDCP is supporting falls into several linked performance areas. First, the recipient is expected to research and analyze a range of existing community-based overdose efforts as well as the current set of evidence-based strategies known to reduce opioid-related overdose deaths. Second, using those evidence-based approaches, the recipient must implement or strengthen new or ongoing community programs aimed at reducing opioid-involved overdoses, with emphasis on high-burden regions. ONDCP signaled that proposals would be viewed more favorably if they push resources outward by issuing subawards, with priority given to proposals that make funding available to at least eight communities. Third, the recipient must support evaluation of the implemented community efforts to determine whether they actually reduce opioid-involved overdoses and related harms. Finally, the program requires intentional support for cross-sector collaboration, meaning the recipient must actively promote and strengthen coordination between public safety and public health agencies so communities receive a more unified, comprehensive response rather than fragmented initiatives. Alongside implementation and evaluation, the recipient is also expected to provide technical assistance to help subaward communities with program rollout, evaluation methods, and reporting requirements.
Eligibility is limited to legally recognized public or private nonprofit institutions and organizations, explicitly including institutions of higher education (public and/or private) and private nonprofit hospitals. Applicants must demonstrate expert knowledge and substantial experience in conducting research and analysis, and also show strong experience developing, improving, or scaling programs that reduce opioid overdoses using strategic, evidence-based methods. A non-negotiable eligibility condition is partnership with a regional HIDTA program. Applications had to include a letter of support or commitment from the participating HIDTA, signed by the sponsoring HIDTA Director, confirming the partnership and engagement.
The administrative deadline required applicants to be registered in Grants.gov before submission, and to submit the application early enough to receive a successful Grants.gov validation message by 5:00 p.m. Eastern Time on September 3, 2019. The opportunity reflects the broader federal response to the opioid crisis described in the notice, including the recognition of overdose as the leading cause of injury death in the United States and the scale of opioid-involved deaths reported by CDC for 2018. In practical terms, the grant is structured to produce both immediate community action and credible, shareable findings by concentrating resources in heavily impacted areas, requiring law enforcement and public health partnership, and emphasizing evaluation and technical support so results can be measured and potentially replicated.Apply for COOCLI1
- The Office of National Drug Control Policy in the health sector is offering a public funding opportunity titled "Combating Opioid Overdose through Community Level Intervention" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 95.007.
- This funding opportunity was created on Aug 23, 2019.
- Applicants must submit their applications by Sep 03, 2019. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $4,500,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Public and State controlled institutions of higher education, Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
FAQs: Combating Opioid Overdose through Community-Level Intervention (ONDCP)
What is the purpose of the Combating Opioid Overdose through Community-Level Intervention opportunity?
This federal funding opportunity is designed to strengthen local and regional responses to the opioid overdose epidemic by supporting hands-on, community-based work that combines implementation with rigorous evaluation. A key goal is to generate practical, real-world evidence about what works, especially in areas experiencing the highest rates of fatal and non-fatal opioid overdoses.
Which federal office is offering this funding?
The opportunity is offered by the Office of National Drug Control Policy (ONDCP) within the Executive Office of the President.
What type of award is this?
The planned award is a cooperative agreement, meaning ONDCP (and related efforts at CDC referenced in the notice) is expected to remain engaged with the recipient and the work is expected to align with related federal overdose response activities.
How many awards were expected to be made?
ONDCP planned to make one cooperative agreement award.
What is the project period for the award?
The planned project period is one year, beginning around September 2019.
What is the maximum funding amount available under this opportunity?
The anticipated award ceiling is $4,500,000.
What funding category and CFDA number are associated with this opportunity?
The award was posted as a discretionary grant in the health funding category under CFDA 95.007.
What is the overall strategy ONDCP is trying to advance through this grant?
The notice emphasizes strengthening coordination across systems that often operate separately, particularly public health and law enforcement. The intent is to support unified, comprehensive community responses rather than fragmented initiatives, while also building credible findings that can be shared and potentially replicated.
What are the main required performance areas or components of work?
The supported work is described across several linked performance areas:
- Research and analysis of existing community-based overdose efforts and evidence-based strategies known to reduce opioid-related overdose deaths.
- Implementation or strengthening of new or ongoing community programs using evidence-based approaches, with emphasis on high-burden regions.
- Evaluation of the community efforts to determine whether they reduce opioid-involved overdoses and related harms.
- Intentional support for cross-sector collaboration between public safety and public health agencies.
- Technical assistance to help subaward communities with program rollout, evaluation methods, and reporting requirements.
Does the opportunity encourage subawards to communities?
Yes. ONDCP signaled that proposals would be viewed more favorably if they push resources outward by issuing subawards.
Is there a preferred number of communities to receive subawards?
The notice indicates priority would be given to proposals that make funding available to at least eight communities.
Are applicants required to focus on certain geographic areas?
The work is intended to concentrate resources in heavily impacted, high-burden regions of the country experiencing the highest levels of fatal and non-fatal opioid overdoses.
How important is evaluation in this program?
Evaluation is a required element. The recipient must support evaluation of implemented community efforts to assess whether they reduce opioid-involved overdoses and related harms, with the broader goal of producing credible, shareable findings.
What does "community-level intervention" mean in the context of this opportunity?
Based on the notice, it refers to hands-on, community-based work that implements or strengthens overdose reduction programs in real-world settings, paired with evaluation and cross-sector coordination to improve outcomes.
What kinds of cross-sector partnerships does ONDCP want to strengthen?
A central theme is improving coordination between public health and law enforcement (public safety), since stronger alignment between these sectors is described as essential to reducing overdose deaths and other opioid-related harms.
How does this opportunity relate to HIDTA?
The program specifically connects to the High Intensity Drug Trafficking Areas (HIDTA) program. HIDTA partnerships are described as a core structural requirement, not an optional collaboration, and the notice references collaboration through the Overdose Response Strategy initiative involving CDC and HIDTA.
Is partnership with a regional HIDTA program required?
Yes. Partnership with a regional HIDTA program is a non-negotiable eligibility condition.
What documentation is required to show the HIDTA partnership?
Applications had to include a letter of support or commitment from the participating HIDTA, signed by the sponsoring HIDTA Director, confirming the partnership and engagement.
Who is eligible to apply?
Eligibility is limited to legally recognized public or private nonprofit institutions and organizations. The notice explicitly includes institutions of higher education (public and/or private) and private nonprofit hospitals.
What experience or capabilities must applicants demonstrate?
Applicants must demonstrate expert knowledge and substantial experience in conducting research and analysis. They must also show strong experience developing, improving, or scaling programs that reduce opioid overdoses using strategic, evidence-based methods.
What is meant by "evidence-based strategies" in this opportunity?
The notice indicates the recipient should analyze evidence-based strategies known to reduce opioid-related overdose deaths and then use those evidence-based approaches to implement or strengthen community programs.
What does the cooperative agreement structure imply for the recipient?
It implies a close working relationship in which ONDCP remains engaged with the recipient, and the funded work is expected to align with and be informed by related federal overdose response activities (including related efforts referenced at CDC).
Is technical assistance to communities part of the required work?
Yes. Alongside implementation and evaluation, the recipient is expected to provide technical assistance to help subaward communities with program rollout, evaluation methods, and reporting requirements.
What was the application submission deadline and time zone?
Applicants needed to submit early enough to receive a successful Grants.gov validation message by 5:00 p.m. Eastern Time on September 3, 2019.
Were applicants required to register in Grants.gov?
Yes. Applicants were required to be registered in Grants.gov before submission.
What does it mean to receive a successful Grants.gov validation message?
Based on the notice, the application had to be submitted early enough so that Grants.gov could process the submission and return a successful validation message by the stated deadline time.
Why does the notice emphasize coordination between public health and law enforcement?
The opportunity is built around the idea that public health and law enforcement often operate separately. The program frames stronger alignment between these sectors as essential to reducing overdose deaths and other harms linked to opioid misuse.
What is the intended outcome beyond immediate community interventions?
Beyond near-term community action, the program is intended to produce credible, practical findings about what works in real-world communities, supported by evaluation, so results can be shared and potentially replicated.
How does the opportunity fit into the broader federal response described in the notice?
The notice situates the program within the broader federal response to the opioid crisis, including recognition of overdose as the leading cause of injury death in the United States and CDC-reported opioid-involved deaths for 2018. The grant design emphasizes concentrated resources, required collaboration, and measurement of results.
Browse more opportunities from the same category: Health
Next opportunity: Great Lakes Fishery Commission
Previous opportunity: Expansion of LandScope Chesapeake
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for COOCLI1
Applicants also applied for:
Applicants who have applied for this opportunity (COOCLI1) also looked into and applied for these:
| Funding Opportunity |
|---|
| Delta States Rural Development Network Grant Program Apply for HRSA 20 087 Funding Number: HRSA 20 087 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $56,604 |
| National Network of Sexually Transmitted Diseases Clinical Prevention Training Centers (NNPTC) Apply for CDC RFA PS20 2004 Funding Number: CDC RFA PS20 2004 Agency: Department of Health and Human Services, Centers for Disease Control - NCHHSTP Category: Health Funding Amount: Case Dependent |
| USAID/Uganda Voluntary Family Planning for Improved Reproductive Health and Development (FP4HD) Activity Apply for 72061719RFA00005 Funding Number: 72061719RFA00005 Agency: Agency for International Development, Uganda USAID-Kampala Category: Health Funding Amount: $24,000,000 |
| The NINDS Human Cell and Data Repository (U24 - Clinical Trial Not Allowed) Apply for RFA NS 19 038 Funding Number: RFA NS 19 038 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $850,000 |
| AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF) Apply for HRSA 20 066 Funding Number: HRSA 20 066 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Catalyze: Product Definition for Small Molecules and Biologics - Preliminary Product/Lead Series Identification (R33 - Clinical Trial Not Allowed) Apply for RFA HL 20 027 Funding Number: RFA HL 20 027 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $350,000 |
| Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed) Apply for RFA HL 20 023 Funding Number: RFA HL 20 023 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $350,000 |
| State and Regional Primary Care Association (PCA) Cooperative Agreements Apply for HRSA 20 021 Funding Number: HRSA 20 021 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Orphans and Vulnerable Children Apply for 72065619RFA00012 Funding Number: 72065619RFA00012 Agency: Agency for International Development, Mozambique USAID-Maputo Category: Health Funding Amount: $14,200,260 |
| STD/HIV Disease Intervention Training Centers (DITC) Apply for CDC RFA PS20 2003 Funding Number: CDC RFA PS20 2003 Agency: Department of Health and Human Services, Centers for Disease Control - NCHHSTP Category: Health Funding Amount: Case Dependent |
| State Offices of Rural Health Coordination and Development Program (SORHCDP) Apply for HRSA 20 085 Funding Number: HRSA 20 085 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $750,000 |
| MD-PhD Training Program in Alzheimer's Disease and Related Dementias and the Behavioral and Social Sciences (T32 Clinical Trial Not Allowed) Apply for RFA AG 20 032 Funding Number: RFA AG 20 032 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Bench to Bassinet Program Administrative Coordinating Center (U01 - Clinical Trial Not Allowed) Apply for RFA HL 21 002 Funding Number: RFA HL 21 002 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $3,417,000 |
| USAID/Uganda Social and Behavior Change for Transformation (SBC4T) Activity Apply for 72061719RFA00007 Funding Number: 72061719RFA00007 Agency: Agency for International Development, Uganda USAID-Kampala Category: Health Funding Amount: $35,000,000 |
| Dementia Care: Home- and Community-Based Services (HCBS) (R21 Clinical Trial Not Allowed) Apply for RFA AG 20 038 Funding Number: RFA AG 20 038 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $250,000 |
| Dementia Care: Home- and Community-Based Services (HCBS) (R01 Clinical Trial Not Allowed) Apply for RFA AG 20 037 Funding Number: RFA AG 20 037 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $400,000 |
| National Health Center Training and Technical Assistance Partners Cooperative Agreements (NTTAP) Apply for HRSA 20 022 Funding Number: HRSA 20 022 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| USAID/Uganda Strengthening Supply Chain Systems Technical Assistance (SSCS) Activity Apply for 72061719RFA00008 Funding Number: 72061719RFA00008 Agency: Agency for International Development, Uganda USAID-Kampala Category: Health Funding Amount: $18,500,000 |
| Service Area Competition Apply for HRSA 20 020 Funding Number: HRSA 20 020 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Strengthening HIV Strategic Information Activities in the Republic of Senegal under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH19 1965 Funding Number: CDC RFA GH19 1965 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $550,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "COOCLI1", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
